Pathways of hepatic regeneration and pharmacological approaches for hepatoprotection: A brief approach

Journal of Pharmacology and Toxicology

Volumn 6, Issue 1, 2011, Pages 24-29

  Ansari, J A ^a   Jamil, M ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Hepatic dysfunctions; Microanatomy; Pharmacological hepatoprotection; Regeneration pathway

Indexed keywords

4 ETHYL 2 HYDROXYIMINO 5 NITRO 3 HEXENAMIDE; ACETYLCYSTEINE; BILE ACID; EPIDERMAL GROWTH FACTOR; FINGOLIMOD; INTERLEUKIN 6; PENTOXIFYLLINE; RAPAMYCIN; SCATTER FACTOR; SEROTONIN; SOMATOSTATIN; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CYCLE PHASE; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG MECHANISM; HUMAN; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER GRAFT REJECTION; LIVER PROTECTION; LIVER REGENERATION; LIVER STRUCTURE; LIVER TRANSPLANTATION; LIVER WEIGHT; LOW DRUG DOSE; MICROSCOPIC ANATOMY; MITOGENESIS; MOLECULAR INTERACTION; NONHUMAN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION;

EID: 77955477184     PISSN: 1816496X     EISSN: 2152100X     Source Type: Journal    
DOI: 10.3923/jpt.2011.24.29     Document Type: Article

References (24)

1. Bucuvalas, J.C, F.C. Ryckman, S. Krug, M.H. Alonso, W.F. Balistreri and U. Kotagal, 2001. Effect of treatment with prostaglandin El and N-acetylcysteine on pediatric liver transplant recipients: A single-center study. Pediatr Transplant, 5: 274-278.
2. Bustos, M, N. Beraza, J.J. Lasarte, E. Baixeras, P. Alzuguren, T. Bordet and J. Prieto, 2003. Protection against liver damage by cardiotrophin-1: A hepatocyte survival factor upregulated in the regenerating liver in rats. Gastroenterology, 125: 192-201.
3. Cressman, D.E., L.E. Greenbaum, R.A. De Angelis, G. Ciliberto, E.E. Furth and V. Poli 1996. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science, 274: 1379-1383.
4. Cunningham, C.C. and C.G. Van Horn, 2003. Energy availability and alcohol-related liver pathology. Alcohol Res. Health, 27: 281-299.
5. David, Z. and D.B. Thomas, 2003. Hepatology: A Textbook of Liver Disease. 4th Edn, W. B. Saunders Co, Philadelphia, ISBN: 0-7216-9051-3.
6. Dhiman, R.K. and Y.K. Chawla, 2005. Herbal Medicines for liver diseases. Digestive Dis. Sci, 10: 1807-1812.
7. Fausto, N., J.S. Campbell and K.J. Riehle, 2006. Liver regeneration. Hepatology, 43: S45-S53.
8. Huang, W, K. Ma, J. Zhang, M. Qatanani and J. Cuvillier et al., 2006. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science, 312: 233-236.
9. Javed, A., A.M. Khan and M.B. Anwar, 2009. Liver toxicity caused by synthetic drugs. J. Chem. Pharm. Sci, 2: 265-269.
10. Lesurtel, M, R. Graf, B. Aleil, D.J. Walther and Y. Tian et al., 2006. Platelet-derived serotonin mediates liver regeneration. Science, 312: 104-107.
11. Man, K., T. K. Lee, T.B. Liang, CM. Lo, P.C. Fung and S.H. Tsui, 2004. FK 409 ameliorates small-for-size liver graft injury by attenuation of portal hypertension and down-regulation of Egr-1 pathway. Ann. Surg, 240: 159-168.
12. Man, K, M. Su, K.T. Ng, CM. Lo and Y. Zhao et al., 2006. Rapamycin attenuates liver graft injury in cirrhotic recipient: The significance of downregulation of Rho-ROCK-VEGF pathway. Am. J. Transplant, 6: 697-704.
13. Mead, J.E. and N. Fausto, 1989. Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc. Natl. Acad. Sci. USA, 86: 1558-1562.
14. Michalopoulos, G.K. and M. DeFrances, 2005. Liver regeneration. Adv. Biochem. Eng. Biotechnol, 93: 101-34.
15. Nocito, A, P. Georgiev, F. Dahm, W. Jochum, M. Bader, R. Graf and P.A. Clavien, 2007. Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice. Hepatology, 45: 369-376.
16. Pediaditakis, P, J.C. Lopez-Talavera, B. Petersen, S.P. Monga and G.K. Michalopoulos, 2001. The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. Hepatology, 34: 688-693.
17. Roger, W. and C. Edwards, 2003. Clinical Pharmacy and Therapeutics. 3rd Edn, Churchill Livingstone: Elsevier Publication, Canada, pp: 209-210, 214, 226.
18. Strain, A.J, A. Frazer, D.J. Hill and R.D. Milner, 1987. Transforming growth factor beta inhibits DNA synthesis in hepatocytes isolated from normal and regenerating rat liver. Biochem. Biophys. Res. Commun, 145: 436-442.
19. Taub, R, 2004. Liver regeneration: From myth to mechanism. Nat. Rev. Mol. Cell. Biol, 5: 836-847.
20. Tian, Y, W. Jochum, P. Georgiev, W. Moritz, R. Graf and P.A. Clavien, 2006. Kupffer cell-dependent TNF-alpha signaling mediates injury in the arterialized small-for-size liver transplantation m the mouse. Proc. Natl. Acad. Sci. USA, 103: 4598-4603.
21. Weigand, M.A, J. Plachky, J.C. Thies, D. Spies-Martin, G. Otto and E. Martin, 2001. N-acetylcysteine attenuates the increase in alpha-glutathione S-transferase and circulating ICAM-1 and VCAM-1 after reperfusion in humans undergoing liver trans-plantation. Transplantation, 72: 694-698.
22. Xu, X, K. Man, S.S. Zheng, T.B. Liang, T.K. Lee and K.T. Ng, 2006. Attenuation of acute phase shear stress by somatostatin improves small-for-size liver graft survival. Liver Transplant, 12: 621-627.
23. Yamada, Y, I. Kirillova, J.J. Peschon and N. Fausto, 1997. Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci. USA, 94: 1441-1446.
24. Zhao, Y, K. Man, CM. Lo, K.T. Ng and X.L. Li et al., 2004. Attenuation of small-for-size liver graft injury by FTY720: Significance of cell-survival Akt signaling pathway. Am. J. Transplant, 4: 1399-1407.